Nephrocare Health Services Ltd (NEPHROPLUS) — Announcement | 18 September 2026

18 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

India Ratings upgraded Nephrocare's long-term bank loan rating to IND AA- and reaffirmed short-term rating at IND A1+.

🔄 What Changed

Long-term bank loan rating upgraded from IND A+ to IND AA-; short-term rating reaffirmed at IND A1+.

💡 Investor Takeaway

The upgrade signals stronger creditworthiness and financial flexibility, supporting future growth initiatives.

Nephrocare Health Services announced that India Ratings upgraded its long-term bank loan facilities to IND AA- from IND A+ with a Stable outlook, while reaffirming the short-term rating at IND A1+. The upgrade reflects improved financial flexibility following an equity raise and stronger operating performance, with cash and equivalents rising to INR4.3 billion and net leverage improving to 0.4x. The company maintains a diversified dialysis business contributing 42% of revenue internationally, but faces working capital intensity and foreign exchange risks.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NEPHROPLUS ✨ Ask AI About This

About Nephrocare Health Services Ltd (NEPHROPLUS)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹6,654.6 CrP/E: 77.8ROE: 7.6%ROCE: 14.6%

View full NEPHROPLUS stock details →

📡 Get AI alerts when NEPHROPLUS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NEPHROPLUS — Free

💡 Ask AI about this filing

"How will the upgraded credit rating impact Nephrocare's ability to secure future financing?""What specific milestones are planned for the Uzbekistan subsidiary's debt repayment?""How does the company plan to manage foreign exchange risks given its 42% international revenue exposure?"

Ask AI Free →

📊 More NEPHROPLUS filings

🔴 Insider Trading — 28 September 2026Polar Capital Funds PLC disclosed through its three healthcare-focused funds a 2.535% off-market pur...
Announcement — 25 September 2026Nephrocare Health Services Ltd announced the closure of its trading window effective October 1, 2026...
🔴 Announcement — 22 September 2026Nephrocare Health Services Ltd announced it will attend an investor conference on September 29, 2026...
🔴 Announcement — 14 September 2026Nephrocare Health Services announced a memorandum of understanding to acquire a Philippine dialysis ...
🟡 Board Meeting — 3 September 2026Nephrocare Health Services approved the grant of 4,01,362 employee stock options under its 2026 ESOP...

See all NEPHROPLUS filings →

🔥 Also filed on 18 September 2026

MAHABANKBank of MaharashtraCorporate Action GODREJINDGodrej Industries LtdCorporate Action THEMISMEDThemis Medicare LtdCorporate Action CREDITACCCreditAccess Grameen LtdCorporate Action ARFINArfin India LtdCorporate Action GUJTHEMGujarat Themis Biosyn LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NEPHROPLUS files new disclosures

Track NEPHROPLUS filings, board meetings, and corporate actions. Free email alerts at 5 PM.